Net Assets per Single Share: bionomics.com.au (NEUP)
Neuphoria Therapeutics Inc. (NEUP) possesses an innovative pipeline for creating ion channel modulators to combat PTSD, which opens broad prospects. This chart of the stock's historical book value demonstrates net asset dynamics, with 4.56 representing the latest level. The company's revenues will be based on the therapy of cognitive impairments; however, geopolitical tensions and sanctions seriously hinder global trials and component logistics.
Summary analytical data breakdowns for Neuphoria Therapeutics, Inc. (NEUP)
- share price and expert price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt and solvency information:
Total Debt to Equity Ratio Neuphoria Therapeutics Inc.|NEUP - Long-Term Debt to Capital|Short-Term Debt to Equity Neuphoria|NEUP - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Neuphoria Therapeutics Inc.|NEUP - Long-Term Debt|Company Short-Term Debt Neuphoria Therapeutics|Quick Ratio bionomics.com.au
- earnings and multiples data:
General company analysis:NEUP - bionomics.com.au
Book value per share determines the net asset value of a company minus all liabilities, serving as a fundamental anchor of capital reliability for the investor. By analyzing book value data on GURU.Markets, one can assess the financial stability of Neuphoria Therapeutics Inc. (NEUP), whose value in the defensive neuropsychiatry sector depends on clinical trial results rather than market conditions.
Main competitors
BIIB: Accounting Value per Share|NBIX - Book Value per Share|Regencell Bioscience (RGC) - Net Assets per Single Share|Share Book Value AXSM (axsome.com)|Net Assets per Single Share ACADIA Pharmaceuticals Inc.|Equity per Share XENE (Xenon Pharmaceuticals Inc.)|Book Value per Share VKTX|SUPN - Net Asset Value per Share|Catalyst Pharmaceuticals - Accounting Value per Share|Book Value per Share denalitherapeutics.com DNLI|HRMY - Net Assets per Single Share|Accounting Value of a Share BHVN (Biohaven Ltd)|Amylyx (AMLX) - Net Assets per Single Share|Net Asset Value per Share Trevi Corp (TRVI)|Net Assets per Single Share Praxis Precision Medicines|Equity per Share AVXL (anavex.com)|Book Value per Share CBLL|PRTA - Net Asset Value per Share|Alector - Accounting Value per Share|Book Value per Share Annexon Biosciences Inc. ANNX|OMER - Net Assets per Single Share|Share Book Value NGNE|ACIU: Book Value per Share|Voyager Therapeutics Inc - Accounting Value of a Share|Net Assets per Single Share Neumora Therapeutics Inc|Net Asset Value per Share Scilex Holding Company, Inc. SCLX|Net Assets per Single Share Tevogen Bio Holdings (TVGN)|ACOG (alphacognition.com) - Accounting Value of a Share|Book Value per Share CGTX (Cognition Therapeutics)|Net Assets per Share Inhibikase Therapeutics Inc (IKT)|Cassava - Book Value per Share|ASRT - Book Value per Share|COYA (coyatherapeutics.com) - Accounting Value per Share|Vistagen - Accounting Value of a Share|Accounting Value per Share OVID|ABOS (Acumen Pharmaceuticals Inc.) - Book Price of a Share|Book Value per Share CRVO|ATHE (alteritytherapeutics.com) - Accounting Value of a Share|Book Value per Share CLNN (Clene)|PepGen Inc (PEPG) - Net Asset Value per Share|JUNS - Net Assets per Single Share|Accounting Value of a Share RLMD (Relmada Therapeutics Inc)|ANVS: Book Value per Share|Grace Therapeutics (GRCE) - Book Value per Share|Net Assets per Single Share Firefly Neuroscience, Inc|ANEW Medical, Inc. - Share Book Value|Book Value per Share NRSN|RVPH - Net Asset Value per Share|MetaVia - Accounting Value per Share|Book Value per Share NeurAxis Inc NRXS|HSDT: Accounting Value per Share|Passage Bio, Inc. - Book Price of a Share|NERV: Book Value per Share|ATHA - Net Assets per Share|ADXN (Addex Therapeutics, Ltd.) - Book Value per Share|Accounting Value per Share Alzamend (ALZN)|Net Assets per Single Share Cyclerion Therapeutics (CYCN)|Net Assets per Share protagenic.com|Pasithea Therapeutics Corp. - Accounting Value per Share|Accounting Value of a Share CRGT|Avenue Therapeutics, Inc - Book Value per Share|Net Assets per Share BrainStorm Cell Therapeutics Inc. BCLI|Cara Therapeutics, Inc. (CARA) - Net Assets per Single Share|Equity per Share CHRO|ELYM (Eliem Therapeutics, Inc.) - Book Value per Share|Accounting Value per Share Intra-Cellular (ITCI)|Accounting Value per Share LBPH (Longboard Pharma)|Net Assets per Share Marinus Pharma|Net Assets per Single Share NKGen Biotech, Inc. NKGN|NRBO: Equity per Share|Sage Therapeutics - Book Value per Share|Net Asset Value per Share Synaptogenix Inc.|TRVN (Trevena, Inc) - Accounting Value per Share|Vigil Neuroscience, Inc. (VIGL) - Book Value per Share|Net Assets per Single Share Anew Medical|cerevel.com - Share Book Value